Mane Street Memphis

Commercial Appeal

Neil Strebig – Memphis Commercial Appeal – December 12, 2023  Tennessee Secretary of State Tre Hargett made a brief visit in Memphis last week.  On Dec. 4, Hargett met with leadership at US Biologic inside their Memphis manufacturing facility at Agricenter International near Shelby Farms Park.  “We want Memphis to thrive,” Hargett said.  The discussion…

Read More

UTHSC Researcher’s Lyme Disease Intervention Headed to Market

On one wall in the modest office of Maria Gomes-Solecki, DVM, a professor in the Department of Microbiology, Immunology & Biochemistry at the University of Tennessee Health Science Center, hangs a framed letter that is the culmination of more than 20 years of work. Dated April 27, the letter is from the U.S. Department of…

Read More

What you need to know to stay safe from ticks this summer

PBS

According to the Centers for Disease Control, as many as 476,000 people in the U.S. contract Lyme disease every year. Climate change and human encroachment into wilderness areas means ticks and the disease-causing bacteria they carry are becoming more common. Dr. Linden Hu, an immunology professor and co-director of the Lyme Disease Initiative at Tufts…

Read More

USDA green-lights Lyme disease vaccine that targets mice hosts

The US Department of Agriculture (USDA) has conditionally licensed an oral vaccine designed to limit the spread of Borrelia burgdorferi, the bacterium that causes Lyme disease. The vaccine is sprayed onto pellets and distributed in natural settings to be consumed by mice. Lyme disease is the nation’s most common vectorborne disease, and the US Centers…

Read More

First Lyme Disease Vaccine Licensed for Mice

MEMPHIS (Precision Vaccinations) The U.S. Department of Agriculture recently issued a Conditional Licensure for a novel oral vaccine against the wildlife spread of Borrelia burgdorferi, the bacterium responsible for Lyme disease. Announced by US Biologic, Inc. on May 9, 2023, this innovative Borrelia Burgdorferi Bacterin vaccine is spray-coated onto pellets that mice consume. As the expression goes, if you give a mouse a vaccine…..…

Read More

US Biologic Announces USDA Conditional Licensure of Oral Lyme Vaccine for Wildlife

MEMPHIS, Tenn. – US Biologic, a leading global entity in the development, commercialization, and distribution of orally delivered vaccines, announces USDA Conditional Licensure of its novel oral vaccine against the wildlife spread of Borrelia burgdorferi, the bacterium responsible for Lyme disease, the number one vector-borne disease in the U.S. The only known vector is the…

Read More

US Biologic Presents Development of a Chewable Flu Vaccine: Offers New Tool to Increase Vaccine Equity, Avoid Needles, and Reduce Pandemics

Dr. Jolieke G. van Oosterwijk, US Biologic Chief Scientific Officer, presented key findings on a chewable flu vaccine that US Biologic is developing in partnership with the Biomedical Advanced Research and Development Authority (BARDA) Division of Research, Innovation, and Ventures (DRIVe) as part of its Beyond the Needle program. The presentation was held at the…

Read More

US Biologic – A Breakthrough: Edible Vaccine in “Gummy” Form

City Current

Host Jeremy C. Park talks with Dr. Jolieke van Oosterwijk, Chief Scientific Officer with US Biologic, who highlights the Memphis-based company developing groundbreaking orally delivered vaccines, changing global disease prevention and allowing safe, effective, and cost-efficient delivery of preventative interventions to wildlife, companion animals, food animals, and humans. During the interview, Jolieke discusses how they…

Read More